---
schema_version: "secwatch.filing_event.v1"
accession: "0001703057-25-000034"
form_type: "8-K"
ticker: "ABCL"
cik: "0001703057"
company_name: "AbCellera Biologics Inc."
filed_at: "2025-12-18T23:59:59+00:00"
generated_at: "2026-05-16T12:45:19.254445+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AbCellera settles Bruker patent litigation; $36M upfront plus ongoing royalties

## Summary
- Bruker to pay AbCellera $36 million upfront as part of global patent settlement.
- Bruker will also pay future royalties on worldwide sales of its Beacon Optofluidic platform.
- Settlement resolves all patent litigation between AbCellera and Bruker globally.
- No other terms of the license agreement were disclosed.

## SEC filing metadata
- accession: 0001703057-25-000034
- form_type: 8-K
- ticker: ABCL
- cik: 0001703057
- company_name: AbCellera Biologics Inc.
- filed_at: 2025-12-18T23:59:59+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1703057/000170305725000034/0001703057-25-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1703057/000170305725000034/abcl-20251218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001703057-25-000034
- JSON: https://secwatch.observer/filing/0001703057-25-000034.json
- Plain text: https://secwatch.observer/filing/0001703057-25-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.